Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation.
Saved in:
| Title: | Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation. |
|---|---|
| Authors: | Zois CE; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. christos.zois@oncology.ox.ac.uk., Hendriks AM; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Pires E; Department of Chemistry, University of Oxford, Oxford, UK., Bridges E; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK., Kalamida D; Department of Oncology, Democritus University of Thrace, Alexandroupolis, Greece., Voukantsis D; The Bioinformatics Hub, Department of Oncology, University of Oxford, Oxford, UK., Lagerholm BC; Wolfson Imaging Centre Oxford, MRC Weatherall Institute of Molecular Medicine, Oxford, UK., Fehrmann RSN; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., den Dunnen WFA; Department of Pathology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Tarasov AI; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK.; School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, UK., Baba O; Tokushima University Graduate School, Tokushima, Japan., Morris J; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK., Buffa FM; Department of Oncology, University of Oxford, Churchill Hospital, Oxford, UK., McCullagh JSO; Department of Chemistry, University of Oxford, Oxford, UK., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Harris AL; Molecular Oncology Laboratories, Department of Oncology, Oxford University, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. adrian.harris@oncology.ox.ac.uk. |
| Source: | Cell death & disease [Cell Death Dis] 2022 Jun 28; Vol. 13 (6), pp. 573. Date of Electronic Publication: 2022 Jun 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-4889 |
|---|---|
| DOI: | 10.1038/s41419-022-05005-2 |
